Header Logo

Connection

IRINA AGOULNIK to Relaxin

Back to Details
This is a "connection" page, showing publications IRINA AGOULNIK has written about Relaxin.
IRINA AGOULNIK
Connection Strength
1.493
Relaxin
  1. Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology. Biochem Pharmacol. 2024 09; 227:116401.
    View in: PubMed
    Score: 0.873
  2. Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2. Commun Biol. 2022 11 04; 5(1):1183.
    View in: PubMed
    Score: 0.195
  3. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists. Biochemistry. 2016 Mar 29; 55(12):1772-83.
    View in: PubMed
    Score: 0.123
  4. Relaxin signaling in uterine fibroids. Ann N Y Acad Sci. 2009 Apr; 1160:374-8.
    View in: PubMed
    Score: 0.076
  5. Relaxin/RXFP1 signaling in prostate cancer progression. Ann N Y Acad Sci. 2009 Apr; 1160:379-80.
    View in: PubMed
    Score: 0.076
  6. Relaxin promotes prostate cancer progression. Clin Cancer Res. 2007 Mar 15; 13(6):1695-702.
    View in: PubMed
    Score: 0.066
  7. The role of relaxin in endometrial cancer. Cancer Biol Ther. 2006 Jan; 5(1):71-7.
    View in: PubMed
    Score: 0.061
  8. Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1. Nat Commun. 2013; 4:1953.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.